Further study using larger cohort is needed to confirm whether FLT4, IFNG, IL17C, IL32, and MANSC1 may be used as potential prognostic biomarkers to discriminate early-stage and advanced CRC. The gene discussed is FLT4; the disease is colorectal carcinoma.